BET bromodomain inhibition reduces maturation and enhances tolerogenic properties of human and mouse dendritic cellsRonald Schilderink, Wouter J. de Jonge, Rab K. Prinjha et al.|Molecular Immunology|2016Cited by 35
Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in ColitisLeonie C.S. De Vries, Wouter J. de Jonge, Mohammed Ghiboub et al.|Journal of Crohn s and Colitis|2020Cited by 23
Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel DiseaseAhmed M I Elfiky, Wouter J. de Jonge, Mohammed Ghiboub et al.|Journal of Crohn s and Colitis|2021Cited by 15
A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s DiseaseAhmed M I Elfiky, Wouter J. de Jonge, Ishtu Hageman et al.|Cells|2022Cited by 7
The Epigenetic Reader Protein SP140 Regulates Dendritic Cell Activation, Maturation and Tolerogenic PotentialMohammed Ghiboub, Wouter J. de Jonge, Matthew Bell et al.|Current Issues in Molecular Biology|2023Cited by 4